Nimotuzumab (Biomab EGFR) is a monoclonal antibody and an endothelial growth factor receptor (EGRF) antagonist.
It also stimulates the immune system against the cancer cells.
It is a targeted therapy used for the treatment of glioma (cancer in the brain and spinal cord), cancer of the head and neck, and nasopharyngeal cancer.
It prevents the growth and spread of the cancer.
The drug is approved for different cancers in different countries.
It has received orphan drug status for the treatment of glioma in the United States and pancreatic cancer in the European Union.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Generic : Nimotuzumab
Price Updated on Jul 08, 2023
It also stimulates the immune system against the cancer cells.
It is a targeted therapy used for the treatment of glioma (cancer in the brain and spinal cord), cancer of the head and neck, and nasopharyngeal cancer.
It prevents the growth and spread of the cancer.
The drug is approved for different cancers in different countries.
It has received orphan drug status for the treatment of glioma in the United States and pancreatic cancer in the European Union.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Biomab EGFR - Biocon Limited
Biomab EGFR Injection
Generic : Nimotuzumab
₹
54350
50mg/1Vial
1Vial
When is Biomab EGFR prescribed?
It is prescribed for -
